FDA Inspection 1000383 — NVE Pharmaceuticals, Inc.

NVE Pharmaceuticals, Inc. — FEI 3000205552

The FDA completed an inspection of NVE Pharmaceuticals, Inc. on December 14, 2016 in Andover, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 14, 2016
Fiscal Year
2017
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Andover, NJ (United States)

Citations

IDCFRDescription
1586921 CFR 111.75(c)Specifications met - verify; finished batch